Andrej Skerjanec
Novartis Oncology
104/3K01
Florham Park
NJ 07932
USA
Name/email consistency: high
- Investigation of the pharmacokinetic interactions of deferasirox, a once-daily oral iron chelator, with midazolam, rifampin, and repaglinide in healthy volunteers. Skerjanec, A., Wang, J., Maren, K., Rojkjaer, L. J. Clin. Pharmacol (2010)
- The clinical pharmacokinetics of darifenacin. Skerjanec, A. Clin. Pharmacokinet (2006)
- FTY720, a novel immunomodulator in de novo kidney transplant patients: pharmacokinetics and exposure-response relationship. Skerjanec, A., Tedesco, H., Neumayer, H.H., Cole, E., Budde, K., Hsu, C.H., Schmouder, R. J. Clin. Pharmacol (2005)